- Ongoing, recruitingHuman Pharmacology (Phase I)- Other
Relative bioavailability of two different formulations of nerandomilast and investigation of the food effect on new formulation following oral administration in healthy adult male and female subjects (an open-label, randomised, single-dose, three-way crossover trial)
This study looks at a new medicine called nerandomilast. We want to see how two different forms of this medicine are absorbed by the body. We'll also check if food changes how a new form of it works, helping us understand the best way to take it.
For: Healthy volunteer trialGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
This study is testing a new medicine, BI 1015550, for people with progressive fibrosing interstitial lung diseases (PF-ILDs). Researchers want to see if it helps improve lung function and is safe to use over about a year.
For: Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)Netherlands · Greece · Slovenia